SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-15-284814
Filing Date
2015-08-10
Accepted
2015-08-10 16:02:03
Documents
3
Period of Report
2015-08-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d78372d8k.htm 8-K 13119
2 EX-99.1 d78372dex991.htm EX-99.1 46587
3 GRAPHIC g78372g33x05.jpg GRAPHIC 5292
  Complete submission text file 0001193125-15-284814.txt   68450
Mailing Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560
Business Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Filer) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36500 | Film No.: 151040680
SIC: 2834 Pharmaceutical Preparations